CELC (Celcuity) E10: $-2.10 (As of Mar. 2026)


CELC Celcuity Inc CELC
26 GF Score
Price $96.34
! 2 Warning Signs
View Full Analysis

What is Celcuity E10?

Celcuity CELC +6.95% 26 E10 is $-2.10 as of Mar. 2026. GuruFocus rates CELC with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Celcuity's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.970. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.10 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-24), Celcuity's current stock price is $96.34. Celcuity's E10 for the quarter that ended in Mar. 2026 was $-2.10. Celcuity's Shiller PE Ratio of today is .


Celcuity  (NAS:CELC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Celcuity E10 Related Terms


Celcuity E10 Historical Data

* Premium members only.

The historical data trend for Celcuity's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celcuity E10 Chart

Celcuity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -2.01

Celcuity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.01 -2.10

CELC vs PTGX, SYRE, KYMR: E10 Comparison

For the Biotechnology subindustry, Celcuity's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celcuity Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celcuity's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Celcuity's Shiller PE Ratio falls into.


CELC
26GF Score
Celcuity Inc CELC
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celcuity E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Celcuity's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.97/330.2130*330.2130
=-0.970

Current CPI (Mar. 2026) = 330.2130.

Celcuity Quarterly Data

per share eps CPI Adj_EPS
201606 -0.122 241.018 -0.167
201609 -0.129 241.428 -0.176
201612 -0.134 241.432 -0.183
201703 -0.147 243.801 -0.199
201706 -0.190 244.955 -0.256
201709 -0.260 246.819 -0.348
201712 -0.170 246.524 -0.228
201803 -0.190 249.554 -0.251
201806 -0.180 251.989 -0.236
201809 -0.180 252.439 -0.235
201812 -0.180 251.233 -0.237
201903 -0.180 254.202 -0.234
201906 -0.170 256.143 -0.219
201909 -0.190 256.759 -0.244
201912 -0.180 256.974 -0.231
202003 -0.220 258.115 -0.281
202006 -0.210 257.797 -0.269
202009 -0.240 260.280 -0.304
202012 -0.250 260.474 -0.317
202103 -0.250 264.877 -0.312
202106 -1.110 271.696 -1.349
202109 -0.410 274.310 -0.494
202112 -0.450 278.802 -0.533
202203 -0.530 287.504 -0.609
202206 -0.670 296.311 -0.747
202209 -0.750 296.808 -0.834
202212 -0.690 296.797 -0.768
202303 -0.550 301.836 -0.602
202306 -0.660 305.109 -0.714
202309 -0.830 307.789 -0.890
202312 -0.640 306.746 -0.689
202403 -0.640 312.332 -0.677
202406 -0.620 314.175 -0.652
202409 -0.700 315.301 -0.733
202412 -0.850 315.605 -0.889
202503 -0.860 319.799 -0.888
202506 -1.040 322.561 -1.065
202509 -0.920 324.800 -0.935
202512 -0.970 324.054 -0.988
202603 -0.970 330.213 -0.970

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-2.10 mean?
Celcuity (CELC) has a E10 of $-2.10 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Celcuity and its competitors.
Is Celcuity's E10 too high?
Celcuity's current E10 is $-2.10. Overall, Celcuity has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Celcuity's E10 compare to PTGX and SYRE?
Celcuity's E10 of $-2.10 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Celcuity and its competitors. Celcuity's current E10 is $-2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celcuity stock overvalued right now?
Celcuity (CELC) has a current E10 of $-2.10. The current E10 is $-2.10. Celcuity's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Celcuity (CELC), the current E10 is $-2.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Celcuity Business Description

Other Exchanges 7VR:Germany
Address 16305 36th Avenue North, Suite 100, Minneapolis, MN, USA, 55446
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.
26GF Score

Get the complete analysis for CELC

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$96.34
Price